Kidney Stones can be an indicator of systemic and cardiovascular disease: Evidence from the Colombian Nationwide Registry Study

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background and Objective: Urolithiasis clusters with metabolic and cardiovascular disorders. We estimated nationwide prevalence of urolithiasis in Colombia and quantified its association with cardio-metabolic comorbidities and major cardiovascular events. Methods: Descriptive, cross-sectional analysis of Individual Health Service Provision Records (RIPS), 2010–2024. Urolithiasis identified by ICD-10. Prevalence reported as % and stratified by sex and age. Associations summarized as prevalence ratios (PRs) comparing association with cardio-metabolic comorbidities in individuals with vs without stones; chi-squared tests with 95% CIs. Results and Limitations: Among 65.4 million encounters, 1,838,661 carried a urolithiasis diagnosis (2.8%). Men slightly higher than women (2.9% vs 2.6%). Metabolic disorders were enriched in stone formers: hypertension 6.6% vs 2.2% (PR≈3.0), dyslipidemia 7.3% vs 2.5% (PR≈2.9), obesity 6.3% vs 2.6% (PR≈2.5), diabetes 7.3% vs 2.6% (PR≈2.8). Cardiovascular events were more frequent: ischemic heart disease 7.4% vs 2.7% (PR≈2.7); stroke 5.5% vs 2.8% (PR≈2.0). Renal involvement showed the largest disparity: CKD 8.9% vs 2.7% (PR≈3.3). In children <10 years, CKD occurred in 3.7% with stones. Limitations: reliance on administrative data (selection/misclassification), no verification of diagnoses, cross-sectional design (no temporality/causality), absence of clinical, behavioral, and socioeconomic covariates, no stone type/severity/recurrence or treatment detail; residual confounding likely. Conclusions In Colombia, kidney stones mark a broader cardio-renal-metabolic phenotype. Routine care for stone formers should include blood pressure, glycemia, lipids, adiposity, and kidney-function assessment plus lifestyle counseling. Health systems may consider urolithiasis as a cardiovascular risk-enhancing factor. Longitudinal studies are needed to define causal pathways, risk trajectories, and cost-effective interventions.

Article activity feed